From bench to bedside: nanomedicine development for intracerebral hemorrhage – exploring microenvironment, innovation, and translation
Open Access
- 14 August 2025
- journal article
- review article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 567
Abstract
Intracerebral hemorrhage (ICH) carries a substantial global disease burden, and although it occurs less frequently than ischemic stroke, it results in a greater loss of disability-adjusted life years worldwide and is associated with one of the poorest prognoses among stroke patients. Due to the mechanisms of secondary injury following ICH, angiogenesis, inflammation, and oxidative stress (OS) levels in brain tissue are regulated by complex molecular pathways, leading to significant changes in the brain microenvironment (BME). While traditional treatments for ICH improve survival rates, they have notable drawbacks and limitations. Nanomedicines, as a promising approach, offer the potential to gradually overcome these limitations and are becoming increasingly important in ICH treatment research. This review provides an updated overview of the mechanisms behind the formation of the post-ICH BME, focusing on angiogenesis, inflammation, and OS. Conventional diagnostic and therapeutic methods are outlined, along with an analysis of their drawbacks and limitations. In addition, the current research status of nanomedicines targeting the post-ICH BME is systematically summarized from three perspectives: angiogenesis, inflammation, and OS. Finally, the progress of nanomedicines in clinical translation is analyzed, highlighting the challenges, opportunities, and future prospects for their application in the context of ICH.Keywords
Funding Information
- Special Research Fund for Central Universities, Peking Union Medical College (3332024110)
- National High Level Hospital Clinical Research Funding (2025-PUMCH-D-001)
- CAMS Initiative for Innovative Medicine (2021-1-I2M-019)
- Peking Union Medical College Hospital Talent Cultivation Program Category C (UBJ11023)
- CAMS Innovation Fund for Medical Sciences (2024-I2M-C&T-B-019)
This publication has 159 references indexed in Scilit:
- A self-assembly peptide nanofibrous scaffold reduces inflammatory response and promotes functional recovery in a mouse model of intracerebral hemorrhageNanomedicine: Nanotechnology, Biology and Medicine, 2016
- Protective role of free and quercetin-loaded nanoemulsion against damage induced by intracerebral haemorrhage in ratsNanotechnology, 2016
- Brain recovery mediated by toll-like receptor 4 in rats after intracerebral hemorrhageBrain Research, 2016
- HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhageNeuroscience, 2015
- A self-assembling nanomaterial reduces acute brain injury and enhances functional recovery in a rat model of intracerebral hemorrhageNanomedicine: Nanotechnology, Biology and Medicine, 2015
- The Effect of CXCL12 on Endothelial Progenitor Cells: Potential Target for Angiogenesis in Intracerebral HemorrhageJournal of Interferon & Cytokine Research, 2015
- Nerve Regeneration and Functional Recovery by Collagen-Binding Brain-Derived Neurotrophic Factor in an Intracerebral Hemorrhage ModelTissue Engineering Part A, 2015
- Frequency of Hematoma Expansion After Spontaneous Intracerebral Hemorrhage in ChildrenJAMA Neurology, 2014
- Fingolimod reduces cerebral lymphocyte infiltration in experimental models of rodent intracerebral hemorrhageExperimental Neurology, 2013
- CD47 functions as a molecular switch for erythrocyte phagocytosisBlood, 2012